2-(AMINOMETHYL)-3-BROMO-5-CHLOROPYRIDINE HCL, 95.0%, 1g

5-Methoxy-3,3-dimethyl-5-oxopentanoic acid, 95%, 250mg

Pieza de transición, 19/26, 29/32, 1 Pieza

4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 1g

5-Isopropyl-2 H -pyrazole-3-carboxylic acid, 97.0%, 10g

1-Cyclopropyl-3-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 1g

5-Pyridin-3-yl-1,3,4-oxadiazol-2-ylamine, 95.0%, 5g

Octafluoroadipic Acid>98.0%(GC)(T)25g

Ethyl 2-amino-1-[trans-4-[(tert-butyldimethylsilyl)oxy]cyclohexyl]-1H-benzo[d]imidazole-5-carboxylate, 98%, 50mg

4-(Trifluoromethyl)phenylacetonitrile, 98.0%, 25g

2-Morpholinothiazol-4-amine hydrochloride, 95.0%, 250mg

N-(4-methylpyridin-2-yl)piperidine-4-carboxamide, 1g

1-methyl-1,3-dihydro-2H-imidazol-2-one, 95.0%, 5g